Which of the following is an appropriate use of CA 19- 9? (A) Screening normal, healthy patients for pancreatic cancer (B) Screening at-risk patients for pancreatic cancer (C) Confirming diagnosis of pancreatic cancer in patients with periampullary mass on CT (D) Monitor for progression of disease following resection and/ or adjuvant therapy (E) None of the above